Psychiatry Research
Volume 109, Issue 2 , Pages 201-205 , 15 March 2002

Prolactin but not ACTH increases during sodium lactate-induced panic attacks

  • Christian Otte

      Affiliations

    • University Hospital Hamburg-Eppendorf, Department of Psychiatry and Psychotherapy, Martinistrasse 52, 20246 Hamburg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-40-42803-3232; fax: +49-40-42803-5546
    • ,
  • Michael Kellner

      Affiliations

    • University Hospital Hamburg-Eppendorf, Department of Psychiatry and Psychotherapy, Martinistrasse 52, 20246 Hamburg, Germany
    • ,
  • Josef Arlt

      Affiliations

    • University Hospital Hamburg-Eppendorf, Department of Psychiatry and Psychotherapy, Martinistrasse 52, 20246 Hamburg, Germany
    • ,
  • Holger Jahn

      Affiliations

    • University Hospital Hamburg-Eppendorf, Department of Psychiatry and Psychotherapy, Martinistrasse 52, 20246 Hamburg, Germany
    • ,
  • Florian Holsboer

      Affiliations

    • Max-Planck-Institute of Psychiatry, Kraepelinstrasse 10, 80804 Munich, Germany
    • ,
  • Klaus Wiedemann

      Affiliations

    • University Hospital Hamburg-Eppendorf, Department of Psychiatry and Psychotherapy, Martinistrasse 52, 20246 Hamburg, Germany

Received 9 May 2001 ,Revised 12 December 2001 ,Accepted 22 January 2002.

References 

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. Washington, DC: American Psychiatric Press; 1987;
  2. Apostolopoulos M, Judd FK, Burrows GD, Norman TR. Prolactin response to d,l-fenfluramine in panic disorder. Psychoneuroendocrinology. 1993;18:337–342
  3. Biondi M, Picardi A. Psychological stress and neuroendocrine function in humans: the last two decades of research. Psychotherapy and Psychosomatics. 1999;68:114–150
  4. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrine Reviews. 1998;19:225–268
  5. Carr DB, Sheehan DV, Surman OS, Coleman JH, Greenblatt DJ, Heninger GR. Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. American Journal of Psychiatry. 1986;143:483–494
  6. Dillon DJ, Gorman JM, Liebowitz MR, Fyer AJ, Klein DF. Measurement of sodium lactate-induced panic and anxiety. Psychiatry Research. 1987;20:97–105
  7. Flores CM, Hulihan-Giblin BA, Hornby PJ, Lumpkin MD, Kellar KJ. Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin. Neuroendocrinology. 1992;55:519–528
  8. Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiological Reviews. 2000;80:1523–1631
  9. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry. 2000;157:493–505
  10. Hollander E, Liebowitz MR, Cohen B, Gorman JM, Fyer AJ, Papp LA. Prolactin and sodium lactate-induced panic. Psychiatry Research. 1989;28:181–191
  11. Kellner M, Herzog L, Yassouridis A, Holsboer F, Wiedemann K. Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic. American Journal of Psychiatry. 1995;152:1365–1367
  12. Kellner M, Wiedemann K. Non-response of adrenocorticotropic hormone in first-ever lactate-induced panic attacks in healthy volunteers. Archives of General Psychiatry. 1998;55:85–86
  13. Levin AP, Doran AR, Liebowitz MR, Fyer AJ, Gorman JM, Klein DF. Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatry Research. 1987;21:23–32
  14. Liebowitz MR, Gorman JM, Fyer AJ, Levitt M, Dillon D, Levy G. Lactate provocation of panic attacks. II: Biochemical and physiological findings. Archives of General Psychiatry. 1985;42:709–719
  15. Liebowitz MR, Gorman JM, Fyer A, Dillon D, Levitt M, Klein DF. Possible mechanisms for lactate's induction of panic. American Journal of Psychiatry. 1986;143:495–502
  16. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R (SCID). New York: New York State Psychiatric Institute, Biometrics Research; 1987;
  17. Targum SD, Marshall LE. Fenfluramine provocation of anxiety inpatients with panic disorder. Psychiatry Research. 1989;28:295–306
  18. Torner L, Toschi N, Pohlinger A, Landgraf R, Neumann ID. Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling. Journal of Neuroscience. 2001;21:3207–3214
  19. Vanvugt DA, Webb MY, Reid RL. Naloxone antagonism of corticotrophin-releasing hormone stimulation of prolactin secretion in rhesus monkeys. Journal of Clinical Endocrinology and Metabolism. 1989;68:1060–1066
  20. Wiedemann K, Herzog L, Kellner M. Atrial natriuretic hormone inhibits corticotropin-releasing hormone-induced prolactin release in man. Journal of Psychiatric Research. 1995;29:51–58
  21. Wiedemann K, Jahn H, Kellner M. Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour. Experimental and Clinical Endocrinology of Diabetes. 2000;108:5–13
  22. Wiedemann K, Jahn H, Yassouridis A, Kellner M. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings. Archives of General Psychiatry. 2001;58:371–377

PII: S0165-1781(02)00014-8

Psychiatry Research
Volume 109, Issue 2 , Pages 201-205 , 15 March 2002

Article Tools

* Image Usage & Resolution